Iovance Biotherapeutics Inc 's ability to collect accounts receivable sequentially worsen to 3.9, pointing to a challenging and on top of that deteriorating business climate for the Biotechnology & Pharmaceuticals industry. Iovance Biotherapeutics Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 94 days, from 93 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 442 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1785 to 2880.

What is Receivable Turnover Ratio?
What is Iovance Biotherapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IOVA Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	70.37 %	15.25 %	18.9 %	19.71 %	89.65 %
Y / Y Revenue Change	65.65 %	44.82 %	17.74 %	15.2 %	92.73 %
Receivable Turnover Ratio (TTM)	3.9	3.93	3.76	3.75	3.77
IOVA's Total Ranking	# 2880	# 1785	# 2372	# 2515	# 2413
Accounts Receivable average collection period days	94	93	97	97	97
Seq. Receivable Change	24.9 %	-0.84 %	23.5 %	11.38 %	-15.51 %
Seq. Revenue Change	39.04 %	-17.68 %	28.64 %	12.52 %	21.55 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 47
Healthcare Sector	# 443
Overall Market	# 2880

Receivable Turnover Ratio Statistics
High	Average	Low
18.22	5.35	3.74
(Mar 31 2024)		(Mar 31 2025)

IOVA Company Profile • Back to IOVA Efficiency Comparisons • Compare IOVA Receivables Turnover Ratio to its Competitors

Financial Statements
Iovance Biotherapeutics Inc 's Accounts Receivable	$ 102 Millions	Visit IOVA's Balance sheet
Iovance Biotherapeutics Inc 's Sales TTM	$ 325 Millions	Visit IOVA's Income Statement
Sources of IOVA's Revenues		Visit IOVA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IOVA's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IOVA's Growth Rates	IOVA's Roa	IOVA's Inventory Turnover Ratio	IOVA's Dividend Comparisons
IOVA's Profitability Ratios	IOVA's Roi	IOVA's Asset Turnover Ratio	IOVA's Dividend Growth
IOVA's Valuation Ratios	IOVA's Roe	IOVA's Financial Strength Ratios	IOVA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Pacs Group Inc	8.75	$ 5,551.038 Millions	$ 634.735 Millions
Acadia Pharmaceuticals Inc	8.70	$ 1,138.643 Millions	$ 130.825 Millions
Fate Therapeutics Inc	8.64	$ 6.491 Millions	$ 0.751 Millions
Tactile Systems Technology Inc	8.62	$ 350.319 Millions	$ 40.623 Millions
Cg Oncology Inc	8.61	$ 6.228 Millions	$ 0.724 Millions
Pediatrix Medical Group Inc	8.54	$ 1,950.625 Millions	$ 228.297 Millions
Sotera Health Company	8.54	$ 1,215.925 Millions	$ 142.378 Millions
Volitionrx Limited	8.50	$ 2.458 Millions	$ 0.289 Millions
Ensign Group Inc	8.50	$ 5,486.708 Millions	$ 645.470 Millions
Tenet Healthcare Corp	8.47	$ 21,812.000 Millions	$ 2,574.000 Millions
Inogen Inc	8.47	$ 354.304 Millions	$ 41.817 Millions
Adapthealth Corp	8.42	$ 3,226.709 Millions	$ 383.393 Millions
Axogen inc	8.42	$ 251.174 Millions	$ 29.846 Millions
Becton Dickinson And Company	8.37	$ 20,840.000 Millions	$ 2,489.750 Millions
Pulse Biosciences Inc	8.35	$ 1.185 Millions	$ 0.142 Millions
Alpha Teknova Inc	8.33	$ 43.407 Millions	$ 5.208 Millions
Rockwell Medical inc	8.31	$ 69.827 Millions	$ 8.400 Millions
Inspire Medical Systems inc	8.25	$ 899.227 Millions	$ 109.027 Millions
Sonoma Pharmaceuticals Inc	8.24	$ 21.920 Millions	$ 2.661 Millions
Madrigal Pharmaceuticals Inc	8.19	$ 1,283.940 Millions	$ 156.857 Millions
X4 Pharmaceuticals Inc	8.17	$ 9.441 Millions	$ 1.156 Millions
Seastar Medical Holding Corp	8.11	$ 1.713 Millions	$ 0.211 Millions
Atricure Inc	8.08	$ 567.747 Millions	$ 70.232 Millions
Concentra Group Holdings Parent Inc	8.07	$ 2,287.465 Millions	$ 283.300 Millions
Penumbra Inc	8.06	$ 1,504.874 Millions	$ 186.788 Millions
Sanuwave Health Inc	8.04	$ 43.903 Millions	$ 5.461 Millions
Sight Sciences Inc	8.04	$ 83.351 Millions	$ 10.368 Millions
Aveanna Healthcare Holdings Inc	8.03	$ 2,602.820 Millions	$ 324.026 Millions
Avita Medical Inc	7.99	$ 75.631 Millions	$ 9.463 Millions
Koru Medical Systems Inc	7.97	$ 45.108 Millions	$ 5.658 Millions

Date modified: 2026-09-26T07:11:48+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.